Professional Summary
Professional Overview
Molly Burich is a seasoned healthcare policy and regulatory affairs professional with extensive expertise in the pharmaceutical industry. As the Senior Director and Head of Public Policy at Otsuka Pharmaceutical Companies (U.S.), she leads the development and implementation of strategic policy initiatives to drive positive industry change and optimize patient access to innovative treatments.
Experience Summary
Current Role
In her current role at Otsuka, Molly is responsible for overseeing the company's public policy agenda, including advocating for favorable regulatory and reimbursement policies, collaborating with industry associations, and engaging with key government stakeholders. She has been instrumental in shaping Otsuka's policy strategy, ensuring the company's interests are effectively represented in the evolving healthcare landscape.
Career Progression
Prior to joining Otsuka, Molly held various leadership positions at Boehringer Ingelheim, where she spearheaded the company's public policy efforts related to biosimilars, pipeline products, and reimbursement. She has also held roles at Xcenda and Avalere Health, where she gained valuable experience in reimbursement strategy, health policy, and government affairs.
Throughout her career, Molly has consistently demonstrated her ability to navigate complex regulatory environments, build coalitions, and drive impactful policy initiatives. Her deep understanding of the healthcare ecosystem and her ability to translate policy objectives into tangible outcomes have made her a respected voice within the pharmaceutical industry.
Academic Background
Molly holds a Bachelor of Arts degree from the University of Virginia, where she specialized in Political Science and Public Policy.
Areas of Expertise
- Healthcare policy and regulatory affairs
- Pharmaceutical industry advocacy and stakeholder engagement
- Reimbursement strategy and patient access
- Biosimilars and pipeline product policy
- Government relations and legislative analysis
Professional Impact
Molly's leadership and strategic thinking have contributed to significant policy victories for her clients and employers. She has successfully advocated for favorable reimbursement policies, collaborated with industry associations to shape regulatory frameworks, and fostered productive relationships with key government stakeholders.
Conclusion
With her extensive experience, deep industry knowledge, and proven track record of achieving policy objectives, Molly Burich is poised to continue making a meaningful impact in the pharmaceutical industry. As the Senior Director and Head of Public Policy at Otsuka, she is well-equipped to navigate the evolving healthcare landscape and drive positive change for the company, its patients, and the broader industry.
